Alterity Therapeutics Limited is an ASX-listed biopharmaceutical company focused on developing treatments for neurological disorders and diseases. Its operations involve the discovery, development, and commercialisation of novel therapeutics. Its projects and objectives include the discovery and development of innovative treatments leveraging its proprietary platform technology to target and modulate the activity of ion channels.